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Research
ABSTRACT
Objective To assess associations between cognitive 
status, intelligibility, acoustics and functional 
communication in PD.
Design Cross-sectional exploratory study of functional 
communication, including a within-participants 
experimental design for listener assessment.
Setting A major academic medical centre in the East of 
England, UK.
Participants Questionnaire data were assessed for 
45 people with Parkinson’s disease (PD), who had self-
reported speech or communication difficulties and did 
not have clinical dementia. Acoustic and listener analyses 
were conducted on read and conversational speech for 
20 people with PD and 20 familiar conversation partner 
controls without speech, language or cognitive difficulties.
Main outcome measures Functional communication 
assessed by the Communicative Participation Item Bank 
(CPIB) and Communicative Effectiveness Survey (CES).
Results People with PD had lower intelligibility than 
controls for both the read (mean difference 13.7%, 
p=0.009) and conversational (mean difference 16.2%, 
p=0.04) sentences. Intensity and pause were statistically 
significant predictors of intelligibility in read sentences. 
Listeners were less accurate identifying the intended 
emotion in the speech of people with PD (14.8% 
point difference across conditions, p=0.02) and this 
was associated with worse speaker cognitive status 
(16.7% point difference, p=0.04). Cognitive status was 
a significant predictor of functional communication 
using CPIB (F=8.99, p=0.005, η2 = 0.15) but not CES. 
Intelligibility in conversation sentences was a statistically 
significant predictor of CPIB (F=4.96, p=0.04, η2 = 0.19) 
and CES (F=13.65, p=0.002, η2 = 0.43). Read sentence 
intelligibility was not a significant predictor of either 
outcome.
Conclusions Cognitive status was an important predictor 
of functional communication—the role of intelligibility was 
modest and limited to conversational and not read speech. 
Our results highlight the importance of focusing on functional 
communication as well as physical speech impairment in 
speech and language therapy (SLT) for PD. Our results could 
inform future trials of SLT techniques for PD.
InTroducTIon
Parkinson’s disease (PD) affects around 1.5% 
of people aged over 65 in Europe.1 Originally 
conceptualised predominantly in terms of its 
motor features,2 PD is now recognised to be a 
multifaceted condition.3 Indeed, non-motor 
symptoms, such as cognitive impairment 
affecting over a quarter of people with PD,4 
are believed to exert a substantial effect on 
quality of life.5 Speech impairment,6 at the 
impairment level of the International Classifi-
cation of Functioning (ICF),7 and functional 
communication difficulties,8 at the ICF activity 
and participation levels, are also widespread 
in PD. The mainstay of medical treatment 
for PD is levodopa-based pharmacotherapy,9 
although non-adherence,10 dyskinesia11 
and a lack of clear benefit on speech and 
cognition are problematic.12–14 Therefore, a 
wide range of supplementary therapies can 
be used, including singing,15 dance16 and 
speech and language therapy (SLT). SLT is 
popular among people with PD and families 
alike,17 but there is no definitive randomised 
controlled trial evidence for the effectiveness 
of currently tested SLT techniques.18 More-
over, the content and focus of SLT provision 
can vary markedly between localities. In the 
UK, the focus has traditionally been on motor 
function. In a survey conducted in 2007, func-
tional communication was not reported to 
Strengths and limitations of this study
 ► We provide the first same-study overview of 
associations at various stages along the potential 
pathway to reduced functional communication in 
Parkinson’s disease (PD).
 ► Ours is the first study to consider the acoustic 
characteristics of the speech of British people with 
PD.
 ► Our study was cross-sectional and therefore cannot 
provide definitive insight into causality.
 ► Studies in this field, including ours, tend to have 
smaller sample sizes than many other fields in 
applied health science research, reflecting both the 
methodological challenges of speech analysis and 
the challenges of recruiting from this population.
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constitute a major part of many UK SLT’s clinical practice 
for PD,19 although clinical contacts suggest that the situ-
ation has improved in recent years. Recently, MSB and 
SMCH published a clinical magazine feature article20 to 
emphasise the importance of functional communication 
to SLT clinicians.
Functional communication has been shown to be more 
important to people with PD than motoric speech impair-
ment.21 Moreover, although it is an important predictor 
of quality of life,22 functional communication has 
received relatively limited research attention compared 
with motoric speech impairment. A systematic review of 
the literature up to July 201523 found that nine studies 
prior to ours had assessed the association between cogni-
tive status and functional communication in PD, of which 
eight had found a positive association. However, none had 
used a cognitive assessment sensitive to mild cognitive 
impairment in PD and a validated outcome measure that 
assessed either communicative effectiveness or communi-
cative participation as a unified concept. Therefore, these 
studies may have failed to detect mild cognitive impair-
ment short of dementia and also to accurately capture 
the concept of functional communication, resulting in 
potential inaccurate measurement of both independent 
and dependent variables. In addition, while three prior 
studies had found an association between intelligibility 
and communicative outcomes, only one study24 25 used 
a standardised validated assessment tool—the Commu-
nicative Effectiveness Survey (CES).24 25 However, CES 
covers the ICF activity level, not the ICF participation 
level. Subsequent to our review, one further large study22 
has assessed functional communication outcomes in PD 
and found that people with PD with self-reported worse 
cognitive status and intelligibility had more difficulties 
in communicative participation. The size of this study is 
a major strength, but the study relied entirely on self-re-
port data, which is a substantial limitation with regard to 
assessing cognitive status and intelligibility accurately.
Taking a wider perspective on communication diffi-
culties in PD and potentially associated risk factors, it is 
important to note that no study in the published liter-
ature has provided an overview of the elements and 
potential mechanisms for change in the pathway from 
cognitive status and motoric speech impairment (acous-
tics) through reduced intelligibility to difficulties with 
emotional conveyance and functional communication in 
PD. There has been no comparative overview of which 
acoustic features are most predictive of reduced intelli-
gibility. However, the available literature suggests that 
increased articulatory phonological distinctiveness26 27 
Table 1 List of acoustic measures with a brief explanation of each
Domain Measure Explanation
Initiation Intensity Objective correlate of loudness, measured in dB SPL
Intensity decay Percentage decay in intensity from first to last sentence
Prosody Mean fundamental frequency (F0) Objective correlate of pitch, measured in Hz
SD of F0 Objective correlate of pitch variation
Speech rate Speaking speed, measured in syllables per second
Adjusted speech rate As per speech rate, but excluding dysfluencies and pause
Acceleration Percentage increase in speech rate from first to last sentence
Adjusted acceleration As per acceleration, but excluding dysfluencies and pause
Pause A measure of hesitation, calculated in ms and expressed as 
percentage of utterance time, using a threshold of 50 ms as the 
minimum significant pause duration
Within-word pause Percentage of pause that occurred within rather than between 
words
Iteration Number of instances of linguistic unit repetition
Within-word iteration Percentage of instances of linguistic unit repetition that 
occurred within rather than between words
Phonation Jitter Relative percentage variation in glottal cycle duration (indicative 
of voicing frequency consistency)
Shimmer Relative percentage variation in glottal cycle amplitude 
(indicative of voicing amplitude consistency)
Harmonic-to-noise ratio A measure of cycle-to-cycle variation in waveform shape 
(indicative of voicing strength)
Articulation Formant Centralization Ratio A measure of vowel distinctiveness
SD of /s/ amplitude A measure of consonant articulation strength
Voice onset time ratio A measure of the ability to differentiate for example ‘bark’ and 
‘park’
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and loudness28 29 may be associated with better intelli-
gibility, with the latter having beneficial effects on the 
distinctiveness of speech in PD besides loudness itself.29 
Additionally, no study of speech acoustics has used speech 
that we considered to be naturalistic conversational 
dialogue—for example, the ‘conversational’ speech in the 
study by Goberman and Elmer30 was a standard passage 
read out in the style of conversational speech. More-
over, the ability to communicate emotions effectively is 
important in everyday life31 and studies have shown that 
reduced pitch variation and facial expression can cause 
negative evaluations of the personality of people with 
PD.32–35 Additionally, people with PD have been shown 
to have impaired perception of the intended emotion in 
the speech of others,36–38 which may relate at least partly 
to impaired mesolimbic processing.39 However, normal 
listeners’ ability to identify specific emotions in the speech 
of people with PD has attracted limited research atten-
tion. Miller et al40 showed that listeners were less likely 
to correctly identify the intended emotion in the speech 
of people with PD when auditory and visual information 
were both available. It was suggested that this effect may 
result from a lack of temporal synchronisation in the 
speech of people with PD. Meanwhile, Pell et al41 also 
found reduced ability to identify emotions in the speech 
of people with PD, especially for anger and disgust, but 
did not assess presentation modality.
Informed by limitations in the existing literature, we 
conducted an exploratory study focusing on functional 
communication in PD as our primary outcome. This is 
an area that has received relatively little research atten-
tion, yet corresponds well to the priorities of people 
with PD.21 We conducted a study to provide an overview 
of associations along the potential pathway to func-
tional communication difficulties in PD, since no prior 
study had done this. In addition, we added an aspect on 
emotional conveyance in order to further investigate the 
possibilities raised by Miller et al40 especially with regard 
to presentation modality effects. Our key research ques-
tions for this study are as follows:
 ► How does cognitive status associate with functional 
communication in PD, as measured by the 
Communicative Participation Item Bank (CPIB, 
primary research question) and CES?
 ► What is the test–retest reliability and convergent 
validity of CPIB in our UK context?
 ► How does intelligibility, in both read and 
conversational sentences, associate with functional 
communication in PD?
 ► What were the acoustic differences between 
the speech of people with PD and conversation 
partners (CPs) in our sample; how did the 
intelligibility of these groups differ in read and 
conversational speech; and what acoustic factors 
predicted intelligibility outcomes?
 ► How did the emotional conveyance of people with 
PD and CPs differ, which mood contrasts were 
particularly affected, and did presentation modality 
(audio vs audiovisual) play a role?
MaTerIals and MeThods
design
In order to assess associations along the potential pathway 
to functional communication difficulties in PD, we 
used a cross-sectional design, into which we embedded 
a within-participants experimental design for listener 
assessment. Ours is a clinical linguistics/academic SLT 
study, rather than epidemiology. Our study also draws on 
some methods commonly used in psychology. Therefore, 
there is no suitable reporting guideline to follow. Ethical 
approval for this study was granted by the National 
Research Ethics Service Committee East of England–
Norfolk. All requisite local governance approvals were 
obtained.
Participants
Our study recruited from the Neurology and Medicine 
for the elderly outpatient clinics at a major academic 
medical centre in the East of England region in 2012–
2013. Patients were eligible for the study if they (1) were 
aged at least 18, (2) had idiopathic PD according to the 
UK Parkinson’s Disease Society Brain Bank criteria,42 
(3) had no clinical indication of dementia, (4) had no 
other serious medical conditions that would affect cogni-
tive status or speech, (5) were not considered by clinical 
staff to be unsuitable for the study, for example, due to 
personal circumstances, (6) were native English speakers 
and (7) reported having some difficulty with their speech 
and/or communication. Participants with PD were asked 
to invite a familiar CP control to join them in the study 
where possible. CPs had to (1) be aged at least 18, (2) 
be a native English speaker, (3) not have PD and (4) not 
have any serious medical problems affecting cognition or 
speech. Written informed consent was obtained from all 
participants prior to the commencement of study proce-
dures.
Measures and data collection
The study consisted of one appointment typically of 
around 45 min after consent, which could take place 
either at home or at the University of East Anglia. 
Initially, participants completed a demographic form, 
Table 2 Key clinical characteristics of people with 
Parkinson’s disease in the full and purposive samples
Measure Full sample Purposive sample
Disease duration 
(years)
6.5 (8.3)* 9.0 (9.5)*
MoCA 22.9 (3.6) 22.2 (3.3)
HADS 11.0 (8.5)* 9.6 (4.8)
LEDD 640.5 (656.5)* 691.5 (1027.3)*
Figures are mean (SD), unless when marked with * in which case 
they are median (IQR).
HADS, Hospital Anxiety and Depression Scale; LEDD, Levodopa 
Equivalent Daily Dose; MoCA, Montreal Cognitive Assessment.
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which for people with PD provided their medication 
information which allowed their Levodopa Equivalent 
Daily Dose (LEDD)43 to be calculated. LEDD served 
as a proxy measure of non-speech-specific PD motor 
symptom severity. Validated assessments of cognitive 
status (Montreal Cognitive Assessment, MoCA),44 45 mood 
(Hospital Anxiety and Depression Scale, HADS),46–48 
communicative effectiveness (CES)24 25 49 and communi-
cative participation (Communicative Participation Item 
Bank, CPIB)50 were completed. CPIB was chosen as our 
primary measure of functional communication since 
it specifically assesses ICF participation level difficulties 
that have been shown to be most important to people 
with PD,21 and also has been thoroughly developed 
using item response theory methods50 and subsequent 
validated in PD in the USA and New Zealand, which are 
English-speaking countries.51Therefore, we assessed test–
retest reliability by sending out a second copy of CPIB by 
post 2 weeks after the study visit and assessed convergent 
validity using CES in our UK setting. As per the terms 
of our ethical approval, cognitive, mood and functional 
communication assessments were only administered to 
participants with PD and not to CPs.
Audiovisual recordings were obtained of all partici-
pants’ (PD and CP) speech at a standardised distance 
of 1.5 m using Panasonic NV-GS17 (Panasonic, Osaka, 
Japan) video cameras. Video was encoded in high-quality 
48 kHz AVI format, from which high-quality 44.1 kHz WAV 
audio files could be extracted. Participants first read a stan-
dardised set of 16 sentences taken from the Assessment of 
Intelligibility of Dysarthric Speech (AssIDS) assessment 
tool.52 Then, participants held a short conversation on a 
topic of their choice in an exercise that was intended to 
offer as naturalistic speech as possible. Besides offering 
support to people with PD in completing questionnaires 
where required, this was the main advantage of including 
familiar CPs in the study—King and Gallegos-Santellan 
have shown that people with dysarthria use different strat-
egies with familiar and unfamiliar conversation partners.53 
Finally, participants read four standardised sentences in 
three ways: happy, sad and neutral. All sentences contained 
words of moderate-to-high frequency and did not have an 
intrinsic emotional connotation. Three of the sentences 
were taken with permission from Miller et al40 namely ‘The 
cake is too yellow’, ‘You dropped the sausages in the trifle’ 
and ‘Sam is not a dog’. One further sentence was gener-
ated by the research team: ‘He went to the park’.
data analysis
Speech sample analysis (acoustics, intelligibility and 
emotional conveyance) was conducted on a purposive 
sample of 20 people with PD and 20 CPs. In order to 
generate our purposive sample, first, any samples that 
suffered from technical failure, other issues such as 
road noise and non-compliance with the task instruc-
tions were excluded. Then, selection sought to achieve 
a balanced profile of demographic and clinical features 
among people with PD and maximise comparability of 
demographics between the PD and CP groups, within 
the bounds of what was available in our sample. Only 
people with PD who provided a CP were considered. Age, 
gender, accent and perceived severity of speech disorder 
were also considered in selection. In particular, it was 
important to ensure generalisability of the PD sample. As 
we used standardised read sentences in the intelligibility 
assessment, we designed this part of the study so that each 
script sentence would only be rated twice by each assessor 
in order to avoid stimulus exposure effects and learning 
bias.54 55 Assessment of self-report measures could be 
conducted on the full sample of 45 people with PD, but 
could not be conducted on CPs as we did not gather these 
data for ethical reasons.
Table 3 Descriptive profile of principal speech and communication measures
People with PD
Conversation partner 
controls
Read sentence intelligibility 81.1 (15.0) 87.9 (3.6)
Conversational sentence intelligibility 55.8 (26.5) 71.9 (13.0)
Emotional conveyance (happy audio) 36.5 (20.5) 55.6 (20.8)
Emotional conveyance (happy audiovisual, %) 54.1 (20.5) 61.4 (13.9)
Emotional conveyance (neutral audio, %) 55.4 (18.0) 46.7 (18.6)
Emotional conveyance (neutral audiovisual,%) 38.5 (25.3) 53.6 (20.8)
Emotional conveyance (sad audio, %) 55.8 (21.3) 64.8 (18.7)
Emotional conveyance (sad audiovisual,%) 55.8 (23.1) 63.0 (25.2)
CPIB (T score) 53.0 (9.6) NA
CPIB (overall rating of degree to which PD affects 
communication, n(%))
Not at all: 11 (24%)
A little: 24 (53%)
Quite a bit: 9 (20%)
Very much: 1 (2%)
NA
Figures are mean (SD) unless stated. Intelligibility is scored as percentage of words correctly identified. Emotional conveyance is scored as 
percentage of tokens for which emotion was correctly identified.
CPIB, Communicative Participation Item Bank; PD, Parkinson’s disease.
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Acoustic (phonetic) analysis was conducted by MSB 
using Praat software (P. Boersma & D. Weenink, Univer-
sity of Amsterdam) and a reliability check of a randomly 
selected 10% sample of acoustic data points drawn from 
10 different participants (25% of the phonetic anal-
ysis sample size) was completed by Senior Lecturer in 
Phonetics, ZRB. Acoustic measures covered four broad 
domains56–58—initiation (the production of airflow), 
prosody (rhythm and melody), phonation (voicing) and 
articulation (the modification of sound waves by the 
resonant properties arising from different vocal tract 
configurations). A list of measures with a brief description 
of each is provided in table 1. Sentence-level parameters 
were calculated for conversational and mood sentences. 
Phoneme-level parameters were additionally calculated 
for the set of 16 standardised read sentences.
Sixty-four assessors (88% female, median age 22) served 
as members of the study team to conduct assessment of 
speech samples for intelligibility and emotional convey-
ance. Assessors had to be (1) members of the University 
of East Anglia (UEA, for ethical reasons), (2) fluent 
English speakers and (3) not having significant expertise 
in listening to disordered speech (eg, SLT staff, final-year 
SLT students and those with a close member with PD or 
working with groups or individuals with PD as part of 
their course or extracurricular activities). Twenty tracks 
(each comprising a different combination of utterances 
and speakers) were created in EditStudio software (Medi-
aChance, Ottawa, Canada) with stimulus allocation based 
on a Latin Square design59 and randomised presentation 
order. All tracks were rated three times and four tracks 
were rated an additional time, meaning that each token 
spoken by each participant was rated by at least three 
different assessors. The intelligibility task was transcription 
and following AssIDS protocol, the outcome measure was 
percentage of words correctly identified. This was scored 
separately for read and conversational sentences and 
the transcript for the latter was agreed between authors 
MSB and SMCH. The emotional conveyance task was to 
circle which of three options (happy, neutral or sad) the 
speaker intended to convey and the outcome measure was 
percentage of moods correctly identified following Miller 
et al.40 In the intelligibility task, all stimuli were presented 
audiovisually, while in the emotional conveyance tasks, 
half were presented audiovisually and half in audio only. 
In all listener assessment tasks, assessors could only listen 
to each sentence once and sentences from people with 
PD and CPs were matched for length. The rationale 
for including an audio-only condition in the emotional 
conveyance assessment was to test the preliminary finding 
by Miller et al40 that listeners were less likely to correctly 
identify the intended emotion in the speech of people 
with PD when auditory and visual information were both 
available. In contrast, for intelligibility assessment, we 
wanted to replicate the most common real-life listening 
conditions through presenting audiovisual information.
Statistical aspects of the study were overseen by Senior 
Lecturer in Medical Statistics, ABC. The sample size was 
powered on the primary research question, to assess the 
relationship between cognitive status and CPIB scores in 
people with PD. Since this is an association rather than 
a group difference, we used a power calculation tool for 
observational designs.60 The effect size to use for the 
power calculation was determined by senior statistician 
ABC informed by (1) preliminary systematic literature 
searches by the research team that later became our system-
atic review23 and (2) the research team’s combined wider 
theoretical, scientific and clinical knowledge and exper-
tise about communication in neurological conditions 
such as PD, which both informed us to expect a moderate 
relationship between cognitive status and functional 
communication in PD. Therefore, a power calculation was 
run to state the minimum number of people with PD we 
would require to have 80% power to detect an expected 
association equivalent to r=0.5 for this relationship. This 
gave us an uncorrected target sample size of 30. Following 
discussion with our steering committee, as approved by 
the ethics board, we decided to recruit a minimum of 
40 and a maximum of 45 people with PD as our attrition 
and exclusion corrected target sample size. The reasons 
for seeking to recruit a minimum of 10 additional partic-
ipants (33%) above the minimum target from the power 
calculation were that (1) we were recruiting from an older, 
often frail population whose clinical severity we did not 
know ahead of the study visit for ethical reasons; (2) our 
study population was a group that may experience high 
fatigue, making the risk of non-completion of the study 
visit difficult to predict; (3) the potential of withdrawal 
of scheduled participants due to death, serious illness 
or other personal reasons; (4) the potential that sched-
uled participants may be ineligible or unwilling/unable 
to give informed consent at the study visit; and (5) the 
fact that our study involved making audiovisual record-
ings in participants’ homes where our speech science 
experts predicted an elevated risk of technical failure and 
issues with recording quality, for example, due to pets 
or road noise. Stata (Stata, College Station, Texas, USA) 
and SPSS (IBM, Armonk, New York, USA) software were 
used for statistical analysis. Appropriate linear regres-
sion models were constructed to assess (1) differences in 
speech acoustics between people with PD and CPs and 
the contribution of cognitive status to speech acoustics of 
people with PD; (2) differences in intelligibility and the 
contribution of cognitive status and particular acoustic 
characteristics; (3) differences in the acoustic correlates 
of happy, neutral and sad mood and the contribution of 
cognitive status; (4) differences in emotional conveyance 
and the contribution of cognitive status and particular 
acoustic characteristics; (5) the contribution of cognitive 
status and intelligibility to functional communication as 
measured by CES and CPIB. The test–retest reliability 
of CPIB was assessed using interclass correlation and its 
convergent validity with CES using correlation. Due to 
the exploratory nature of the study, the fact that analysis 
was on a range of outcome measures rather than repeated 
analysis of the same outcome measure and the fact that all 
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comparisons were planned in advance, it was decided a 
priori not to perform adjustment for multiple testing.61 A 
p value of p<0.05 was considered significant and variables 
associated at p<0.1 were retained in models as margin-
ally significant. There were limited missing data, only 
one participant had missing data for the CPIB outcome 
measure and none for CES. Full-case analysis was used.
resulTs
Participants
Forty-five people with PD and 29 CPs were recruited. 
Forty-five people with PD contributed to the question-
naire analysis. The mean age was 71.0 (SD 8.1), 28 (62%) 
were male and the most common educational category 
was to have no formal educational qualifications (n=17, 
38%).
Among the 20 people with PD whose data were used for 
speech sample analysis, the mean age was 71.1 (SD 9.0), 
23 (65%) were male and the most common educational 
category was shared between no formal educational qual-
ifications and vocational qualifications (both n=7, 35%). 
Table 2 presents the clinical characteristics of both the 
full (n=45) and purposive (n=20) samples of people with 
PD.
Among the 20 CPs whose data were used for speech 
sample analysis, the mean age was 70.0 (SD 10.4), 7 (35%) 
were male and the most common educational category 
was to have vocational qualifications (n=8, 40%).
speech acoustics and intelligibility
Table 3 profiles the principal speech and communication 
measures in our study. The overall concordance rate was 
r=0.99 for inter-rater reliability of acoustic measures. In 
read sentences, people with PD had lower speech inten-
sity and greater pause time than CPs. For other measures, 
there was either no significant difference, a marginally 
significant difference or an effect that applied only for one 
gender. MoCA was associated with intensity, although the 
effect was in opposite directions for men and women—
men with PD with better cognitive status spoke more 
loudly, while women with PD with better cognitive status 
spoke more quietly. MoCA was not associated with pause. 
In conversational sentences, people with PD had higher 
within-word iteration than CPs. This was not associated 
with MoCA. Statistical details on the main effects and 
interactions can be found in online supplementary tables 
1 (read sentences) and 2 (conversational sentences).
Assessors were significantly less accurate in tran-
scribing both the read (mean difference=13.7 percentage 
points, p=0.009) and conversational (mean differ-
ence=16.2 percentage points, p=0.04) speech of people 
with PD compared with CPs. In neither case was there 
an association between MoCA and intelligibility. In read 
sentences, intensity (mean difference=2.4 percentage 
points per dB SPL, p=0.04) and pause (mean differ-
ence=3.6 percentage points per percentage unit change 
in pause, p=0.04) were identified as significant predictors 
of listener accuracy—assessors were more accurate in 
transcribing the read speech of people with PD who spoke 
more loudly and paused less. No significant acoustic 
predictors of conversational sentence intelligibility 
were identified. Gender was not a statistically significant 
predictor of intelligibility.
emotional conveyance
In the emotion sentences, men with PD spoke more quietly 
than CPs, women with PD had significantly reduced 
mean fundamental frequency compared with CPs, both 
men and women with PD had significantly reduced SD 
of fundamental frequency, men with PD had significantly 
reduced speech rate (but not adjusted speech rate) and 
both men and women with PD had significantly increased 
pause time. In the PD group, participants with MoCA 
below median had significantly lower speech rate and 
adjusted speech rate. Main effects of mood were found 
within the PD group for most measures, meaning that 
people with PD were on the whole able to distinguish 
emotions in their speech, although distinctions were 
reduced relative to CPs. Significant and marginally signif-
icant group by emotion interactions, for happy versus sad, 
suggests that people with PD were particularly impaired 
in the production of happy emotion. Statistical details 
on the main effects and interactions can be found in 
online supplementary table S3.
Listeners were significantly less accurate in identifying 
the intended emotion (happy, neutral or sad) in the 
speech of people with PD compared with CPs (mean 
difference=14.8 percentage points, p=0.04). A significant 
interaction between group and emotion (mean differ-
ence for group * emotion (sad vs happy)=17.8 percentage 
points, p<0.001) shows that the impact of PD on listener 
accuracy was greater for happy mood. There was no 
significant effect of presentation modality (audiovisual vs 
audio only) on listener accuracy. There was a significant 
effect of MoCA (mean difference=16.7 percentage points 
between participants scoring above and below the median, 
p=0.04), showing that listeners had more difficulty in 
identifying emotion in the speech of people with PD with 
greater cognitive impairment. A significant interaction 
between MoCA and emotion (mean difference for MoCA 
(median split) * emotion (sad vs happy)=23.2 percentage 
points, p=0.009), showing that the differential effect of 
PD on happy mood conveyance was less for those with 
more intact cognition.
CPIB showed satisfactory test–retest reliability (r=0.85, 
p<0.001) and validity (r=0.74, p<0.001) in our popu-
lation, noting that CPIB and CES are measures of 
related but not identical constructs, so a higher concor-
dance would have been unexpected. In the full sample, 
MoCA (F=8.99, p=0.005, η2 = 0.15) and HADS (F=8.73, 
p=0.005, η2 = 0.15) were retained as significant predic-
tors of CPIB, while HADS (F=20.18, p<0.001, η2 = 0.32) 
was the only significant predictor of CES, but there was 
also a marginally significant finding for LEDD (F=3.72, 
p=0.06, η2=0.06). With regard to MoCA subdomains, the 
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executive and visuospatial (F=3.22, p=0.08, η2=0.05) and 
attention (F=3.05, p=0.09, η2=0.05) subdomains were 
both marginally significant predictors of CPIB. Among 
the purposive sample for whom intelligibility scores were 
available, MoCA (F=5.32, p=0.04, η2=0.20) and intelli-
gibility in conversational sentences (F=4.96, p=0.04, η2 
= 0.19), but not intelligibility in read sentences, were 
significant predictors of CPIB, while only intelligibility 
in conversational sentences (F=13.65, p=0.002, η2 = 0.43) 
was a significant predictor of CES.
dIscussIon
The study presented in this article is the first to provide an 
overview of associations along the potential pathway from 
cognitive status and motoric speech impairment (acous-
tics) through reduced intelligibility to difficulties with 
emotional conveyance and functional communication in 
PD. We also include a combination of self-reported and 
observed measures, an approach which avoids one of the 
key limitations associated with larger studies, such as that 
by McAuliffe et al22 that only include self-report measures. 
Ours is also the first to study the acoustics of the speech 
of British people with PD, mindful that there are notable 
acoustic differences between British and American 
English.62 63
The first main finding was that intelligibility was reduced 
in both read and conversational speech for people with 
PD compared with controls, and the effect was greater 
on conversational sentences, potentially reflecting the 
greater cognitive and perceptual challenges of sponta-
neous speech. The second main finding was that acoustic 
differences between people with PD and CPs in our 
sample were modest and few were statistically significant, 
although many participants in our study had relatively 
mild motoric speech difficulties. The results of our study 
reflect the natural hierarchy that can emerge in clinical 
practice, starting initially with work on physical aspects 
of read speech due to the cognitive demands of altering 
one’s speech and then progressing to less structured tasks 
that generalise more readily to everyday conversation (RA 
Atkinson, personal communication, 2016).
The third main finding was that emotional conveyance, 
especially of happy emotion, was impaired in people with 
PD compared with CPs. The fourth main finding was 
that, despite a relatively mild profile of motoric speech 
deficits, participants often had difficulties with functional 
communication. Intelligibility did not account for a large 
proportion of variance in functional outcomes, empha-
sising the need to account for and include other elements 
in functional communication tasks in SLT for people with 
PD to overcome the challenge with generalisation from 
the clinic to everyday life. Cognitive status predicted CPIB 
and emotional conveyance, but not intelligibility or CES. 
This may imply a greater role for cognitive status with 
regard to participation-level phenomena.
Our identification of reduced intelligibility in people 
with PD compared with CPs is in line with previous studies 
and in particular our identification of intensity as a key 
predictor of intelligibility (although only found for read 
sentences in our study) corroborates the prior findings 
of Tjaden and Sussman28 and Neel,29 while our identi-
fication of pause suggests a potentially novel acoustic 
correlate of intelligibility in PD. Our study is the first to 
compare conversational and read speech intelligibility in 
PD and found that intelligibility was lower in conversa-
tional sentences, which is explicable in terms of contextual 
effects and the lower distinctiveness of more spontaneous 
speech and therefore the potential for a lower ability on 
the behalf of listeners to adjust for phonetic alterations.
With regard to emotional conveyance, in keeping with 
Miller et al40 and Pell et al41 our findings support the view 
that people with PD were less successful in conveying 
emotion in their speech. Our findings show that the 
communication of happy emotion was particularly 
affected, although our study cannot confirm the mech-
anisms which might be causing this effect. Unlike Miller 
et al,40 potentially due to lesser severity of speech impair-
ment, we did not find that listeners were more accurate in 
the audio only condition compared with the audiovisual 
condition. Our identification that intelligibility contrib-
utes a relatively modest proportion of the variance in 
functional communication is consistent with Donovan 
et al,24 25 although we advance this knowledge by demon-
strating differences between conversational and read 
sentence intelligibility as well as communicative effective-
ness and communicative participation. Previous studies 
in our review23 and also McAuliffe et al22 have generally 
found an association between cognitive status and func-
tional communication. The prior study by Miller et al,6 64 
which did not find such as association, used as a measure 
of cognitive status the Mini Mental State Examination,65 
which has been shown to be insensitive to mild cognitive 
impairment in PD.66–69
Communication is fundamental to humanity and 
in particular the development and maintenance of 
human relationships.70 Although participation may 
mean different things to different people,71 it is evident 
that participation aspects, including those of functional 
communication,21 are of great importance to people with 
PD. Indeed, it is important that research and clinical 
priorities and perspectives match those of people with the 
condition as closely as possible.72 The relatively modest 
contribution of intelligibility to functional communica-
tion outcomes shown by our study and others indicates 
that it is important for SLT for people with PD to focus 
on non-motoric issues affecting functional communica-
tion in addition to more traditionally recognised motoric 
issues. In environments where there has been a move to 
include a higher proportion of functional communication 
in therapy, this should be maintained. In environments 
where this has not yet happened, it is recommended that 
greater focus on functional communication be consid-
ered. In achieving this, it is important to consider what the 
particular client’s communication needs and goals are, 
what challenges the client faces in accomplishing these 
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and what approaches may facilitate this. It is important 
to remember that communication needs differ between 
clients, and that clients differ in what they consider full 
participation in life.71 Further research is required to 
investigate the effectiveness of SLT for PD. The pathway 
proposed by our study could be useful to inform future 
research into defining treatments to include in interven-
tion trials. In addition, it is important to conduct further 
research into the gender-specific aspects of communi-
cation difficulties in PD, which have received limited 
research attention.
There are some limitations of this study that should be 
taken into account. The PhD time scale did not allow us 
to undertake a longitudinal study, so we cannot be defin-
itive about causality. Second, it was not possible to use 
the entire sample size for speech sample analysis due to 
the constraints that read sentences impose on the sample 
size in the intelligibility assessment so as to avoid learning 
biases. Third, the sample we recruited had on average 
relatively mild motoric speech deficits, potentially due to 
greater reluctance to take part in speech studies among 
those with more severe speech impairment or alterna-
tively due to an over-representation of people with early 
PD and greater insight into research. Fourth, reflecting 
both the methodological challenges of speech analysis 
and the challenges of recruiting from this population, 
sample sizes in this field tend to be lower than in many 
other areas of applied health research. Fifth, we were 
unable to measure motor disability directly. However, we 
offered LEDD as a proxy measure of motor disability to 
models assessing functional outcomes in order to mini-
mise confounding by motor disability. Moreover, some 
studies have shown that cognitive impairment can be 
common in people with PD who are early on the motor 
decline pathway.73 74 However, LEDD has limitations as a 
proxy measure of motor status. For example, one study75 
found no significant association between LEDD and 
Hoehn and Yahr staging. Therefore, future studies should 
consider assessing how scores from explicit motor assess-
ments, such as the Universal Parkinson’s Disease Rating 
Scale,76 predict functional communication outcomes. 
Sixth, due to regulatory constraints, we were unable to 
conduct further analyses following the Chief Investiga-
tor’s departure from the host institution on completion 
of his PhD. Without this restriction, we may have been 
able to consider whether different modelling or reporting 
options may have been preferable.
In conclusion, we present the first study that provides 
an overview of the potential pathway from cognitive 
status and motoric speech impairment through reduced 
intelligibility to difficulties with emotional conveyance 
difficulties and functional communication in PD. Our 
results support the idea that SLT for people with PD 
should focus on functional communication as well as 
motor deficits, and could also inform future trials to 
identify the optimal form of therapy. The pathway to 
functional communication difficulties in PD is likely to 
involve complex, multifactorial mechanisms for change, 
including motoric, cognitive and psychosocial elements. 
Since our study is exploratory, future confirmatory 
research is required to validate and extend our findings. 
This should include clarification of the elements and 
mechanisms of this pathway, as well as how they may differ 
between individuals with PD, which is a condition known 
to vary considerably in its clinical expression.77
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